SuperworthEnveric Biosciences shares outstanding ENVB
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 4M
- On a year earlier
- +1743.2%
- more shares
Enveric Biosciences had 4M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1743.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 54.7K | −71% |
| FY2023 | 190.3K | +10% |
| FY2022 | 173.2K | +221% |
| FY2021 | 54K | +458% |
| FY2020 | 9.7K | −7% |
| FY2019 | 10.4K | +1635% |
| FY2018 | 600 | +118% |
| FY2017 | 275 | +19% |
| FY2016 | 231 | −4% |
| FY2015 | 240 | −6% |
| FY2014 | 254 | +26% |
| FY2013 | 202 | +0% |
| FY2012 | 202 | −2% |
| FY2011 | 205 | +90% |
| FY2010 | 108 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 4M | +1743% | |
| Q1 FY26 | 1.5M | +908% | |
| Q3 FY25 | 313.2K | +548% | |
| Q2 FY25 | 216.3K | +413% | |
| Q1 FY25 | 149.8K | +574% | |
| Q4 FY24 | 54.7K | −71% | |
| Q3 FY24 | 48.4K | −73% | |
| Q2 FY24 | 42.2K | −76% | |
| Q1 FY24 | 22.2K | −87% | |
| Q4 FY23 | 190.3K | +10% | |
| Q3 FY23 | 180.4K | +21% | |
| Q2 FY23 | 175.6K | +100% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Enveric Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.